Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend
BSE moved higher with 22 September in focus.
22 Sept 2026 · LiveMint Markets
Mankind Pharma shares rose more than 2% in intraday trade on the BSE on Tuesday, 22 September, defying weak stock market sentiment. At the price of ₹2,481, Mankind Pharma stock has gained 10.4% in just four sessions.
Key facts
- Dates in focus
- 22 September
The analysis
BSE reported ₹2,481,, with movement of 2%, 10% and 10.4% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With BSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on Monday
Stock Market Today LIVE: Sensex Rises 500 Points, Nifty 50 Holds 22,700; India VIX Leaps 7%; Trent Rallies 12%
Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
Buy, Sell Or Hold: HDFC Bank, Sun Pharma, Rallis India, Trent | Ask Profit